<DOC>
	<DOCNO>NCT01555528</DOCNO>
	<brief_summary>This Mexican , Multicentre , Observational Study evaluate Adherence Long Term Outcomes Therapy paediatric subject use easypod™ electromechanical device growth hormone treatment assess level adherence subject receive SAIZEN® via easypod™ .</brief_summary>
	<brief_title>To Assess Level Adherence Subjects Receiving SAIZEN® Via Easypod™ Mexico</brief_title>
	<detailed_description>Subjects enrol multicenter longitudinal observational study . Parents patient provide Informed Consent upload data population-based analysis optionally adhere patient adherence support program `` AUMENTA '' design improve adherence , ultimately , clinical outcome . Adherence data primarily derive easypod™ device combine physician data entry outcome measure . Data collect retrospectively prospectively . This allow establishment adherence profile explore hypothesis patient adherence support program improve adherence subsequent clinical outcome . Collected data also analyze multinational pooled analysis comparable national study . Primary Objective : -To ass level adherence subject receive SAIZEN® via easypod™ Secondary Objectives : - To describe impact adherence clinical outcome subject receive SAIZEN® via easypod™ - To identify adherence subject profile - To asses impact adherence IGF1 ( i.e . , within normal range ) - To assess/describe impact Mexico patient support program `` AUMENTA ''</detailed_description>
	<mesh_term>Growth Disorders</mesh_term>
	<criteria>Administered growth hormone via easypod™ electromechanical device accord local Prescribing information Over age &gt; 2 year Under &lt; 18 year age , 18 without fusion growth plat Parents ' guardian 's write informed consent , give enter data observational study , understand subject parents/guardian may withdraw consent time without prejudice future medical care . If child old ( 18 without fusion growth plate ) able give write informed consent , separate assent form give Patient sign informed consent 717 year old Patient sign informed consent 18 year old Subjects take growth hormone growth plate fuse ( i.e . take growth hormone 's metabolic effect ) Contraindications SAIZEN® define local prescribe information Use investigational drug participation another interventional clinical study</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Growth disorder</keyword>
	<keyword>Saizen</keyword>
	<keyword>Easypod</keyword>
	<keyword>Growth hormone</keyword>
	<keyword>Pediatric subject</keyword>
</DOC>